Alberto Margonato

Prof. Alberto Margonato serves as Head of the Clinical Cardiology Unit at IRCCS Ospedale San Raffaele in Milan and holds a Full Professorship in Cardiology at Vita-Salute San Raffaele University. With over 40 years of clinical and academic experience, he directs cardiology outpatient services, organizes national congresses, and leads cardiovascular research initiatives. His institutional affiliations span Italy's premier cardiac center and its affiliated medical university, with historical ties to London's Hammersmith and Harefield Hospitals through specialized cardiovascular training.

His educational foundation includes an MD (1976) and triple specializations in Cardiology (1978), Diabetology (1981), and Internal Medicine (1986) from Università degli Studi di Milano, complemented by advanced cardiovascular training at London's Royal Postgraduate Medical School (1983-1985). This multidisciplinary training underpins his integrated approach to complex cardiac cases involving metabolic and systemic comorbidities.

Prof. Margonato's research spans interventional cardiology, heart failure pathophysiology, and diagnostic innovation. His work explores metabolic modulation therapies (particularly trimetazidine), myocardial viability assessment through hybrid imaging techniques, exercise-induced ischemia mechanisms, and sudden cardiac death risk stratification. He has pioneered methodologies combining echocardiography with nuclear imaging for detecting tissue viability and pulmonary edema during stress testing, with applications in refractory angina and chronic total occlusion management.

His publication trajectory shows consistent contributions to high-impact cardiology journals, evolving from foundational work on dipyridamole stress testing (1980s) through metabolic heart failure research (2000s) to contemporary studies on chronic total occlusion outcomes (2019). The research demonstrates methodological progression from observational studies to randomized clinical trials, with increasing focus on personalized risk assessment and metabolic therapeutics.

As a clinical educator, Prof. Margonato supervises through hands-on procedural training in a high-volume interventional environment, having performed over 3,000 catheterizations and 2,000 angioplasties. His unit provides BLS-certified emergency response capabilities and serves as a regional referral center for complex coronary interventions. Current clinical activities include teleconsultation services for international patients and leadership in national cardiology congress organization.